Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Haematologica|July 17, 2010
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistanceRachel E Hayden, Guy Pratt, Mark T Drayson, et al.
Clinical Case Reports|October 29, 2015
Sclerosing angiomatoid nodular transformation of the spleenVidhya Murthy, Ben Miller, Emmanuel M Nikolousis, et al.
British Journal of Haematology|July 2, 2024
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice PaperMartin Kaiser, Guy Pratt, Ceri Bygrave, et al.
Blood|July 29, 2008
Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaOliver C Goodyear, Guy Pratt, Andrew McLarnon, et al.
Leukemia & Lymphoma|August 5, 2011
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesRachel E Hayden, Guy Pratt, Claudia Roberts, et al.
Rheumatology (Oxford, England)|June 22, 2019
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fracturesGuido Nador, Karthik Ramasamy, Fotios Panitsas, et al.
Oncotarget|April 9, 2017
Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartmentsOliver C Goodyear, Sarah Essex, Anandram Seetharam, et al.
Blood|September 8, 2005
CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenOliver Goodyear, Karen Piper, Naeem Khan, et al.
Leukemia & Lymphoma|December 3, 2005
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers and survival in multiple myelomaShankaranarayana Paneesha, Jane Starczynski, Chris Pepper, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|December 5, 2018
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrowZbigniew Rudzki, Richard Lovell, Ben Miller, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Haematologica|July 17, 2010
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistanceRachel E Hayden, Guy Pratt, Mark T Drayson, et al.
Clinical Case Reports|October 29, 2015
Sclerosing angiomatoid nodular transformation of the spleenVidhya Murthy, Ben Miller, Emmanuel M Nikolousis, et al.
British Journal of Haematology|July 2, 2024
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice PaperMartin Kaiser, Guy Pratt, Ceri Bygrave, et al.
Blood|July 29, 2008
Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaOliver C Goodyear, Guy Pratt, Andrew McLarnon, et al.
Leukemia & Lymphoma|August 5, 2011
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesRachel E Hayden, Guy Pratt, Claudia Roberts, et al.
Rheumatology (Oxford, England)|June 22, 2019
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fracturesGuido Nador, Karthik Ramasamy, Fotios Panitsas, et al.
Oncotarget|April 9, 2017
Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartmentsOliver C Goodyear, Sarah Essex, Anandram Seetharam, et al.
Blood|September 8, 2005
CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenOliver Goodyear, Karen Piper, Naeem Khan, et al.
Leukemia & Lymphoma|December 3, 2005
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers and survival in multiple myelomaShankaranarayana Paneesha, Jane Starczynski, Chris Pepper, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|December 5, 2018
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrowZbigniew Rudzki, Richard Lovell, Ben Miller, et al.
Pageof 14